Table 4.
Showing the details of treatment received
| Treatment* | First wave (n=1039) n (%) |
Second wave (n=991) n (%) |
P value† |
| Dexamethasone | 178 (17.1) | 473 (47.7) | <0.001 |
| Anticoagulation | 1012 (97.4) | 981 (99) | 0.007 |
| Favipiravir | 230 (22.1) | 704 (71) | <0.001 |
| Hydroxychloroquine | 920 (88.5) | 598 (60.3) | <0.001 |
| Lopinavir/ritonavir | 369 (35.5) | 630 (63.6) | <0.001 |
| Anakinra | 28 (2.7) | 105 (10.6) | <0.001 |
| Tocilizumab | 21 (2.0) | 19 (1.9) | 0.866 |
| Amoxicillin/clavulanic acid | 633 (60.9) | 290 (29.3) | <0.001 |
| Ceftriaxone/cefuroxime | 772 (74.3) | 699 (70.5) | 0.058 |
| Azithromycin/clarithromycin | 770 (74.1) | 415 (41.9) | <0.001 |
| Piperacillin/tazobactum | 51 (4.9) | 68 (6.9) | 0.061 |
In all statistical comparative analysis performed, second wave was considered as a reference group.
*Some patients might have received more than one type of treatments.
†Pearson χ2 test.